Lineage Cell Therapeutics Balance Sheet (2010-2025) | LCTX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)	56.21M	62.00M	60.81M	55.74M	78.06M	70.86M	24.75M	50.62M	15.45M	33.89M	31.47M	29.93M	43.58M	29.62M	27.75M	45.79M	40.64M	42.27M	32.22M	45.97M
Short-term Investments (Quarter)	6.15M	6.75M	4.29M	2.62M	1.88M	1.17M	41.60M	46.52M	31.36M	12.04M	9.86M	0.05M	0.04M	8.87M	4.96M	2.02M	0.02M	0.02M	0.02M	14.99M
Cash & Current Investments (Quarter)	62.36M	68.75M	65.10M	58.36M	79.94M	72.03M	66.36M	97.14M	46.81M	45.92M	41.33M	29.98M	43.62M	38.50M	32.71M	47.80M	40.66M	42.29M	32.24M	60.95M
Receivables - Net (Quarter)	0.11M	0.33M	2.12M	50.64M	0.32M	0.53M	0.43M	0.30M	0.20M	0.41M	0.43M	0.70M	0.08M	0.23M	0.41M	0.64M	0.21M	0.26M	0.13M	0.89M
Receivables - Other (Quarter)				0.54M		0.20M	0.55M	0.58M											0.55M	0.67M
Receivables (Quarter)	0.11M	0.33M	2.12M	51.17M	0.32M	0.73M	0.98M	0.88M	0.20M	0.41M	0.43M	0.70M	0.08M	0.23M	0.41M	0.64M	0.21M	0.26M	0.68M	1.56M
Inventory (Quarter)
Current Deferred Tax Assets (Quarter)
Prepaid Assets (Quarter)	2.15M	2.50M	3.16M	2.35M	1.41M	1.29M	1.72M	1.83M	2.64M	2.12M	1.72M	2.20M	2.02M	1.66M	1.28M	2.55M	1.87M	1.30M	1.65M	2.48M
Current Assets (Quarter)	64.62M	71.58M	68.34M	111.55M	81.87M	74.03M	68.51M	60.00M	49.66M	48.49M	43.48M	38.44M	45.72M	40.39M	34.40M	51.00M	49.98M	43.84M	42.26M	59.16M
Non-Current Assets
Construction in Progress (Quarter)
Property, Plant & Equipment (Net) (Quarter)	5.11M	5.01M	4.73M	4.87M	4.55M	3.87M	4.65M	5.67M	5.58M	5.31M	4.85M	2.25M	2.10M	2.02M	2.01M	2.25M	2.15M	2.25M	2.16M	2.57M
Long-Term Investments (Quarter)
Goodwill (Quarter)	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M
Intangibles (Quarter)	14.84M	46.89M	46.50M	46.82M	46.79M	66.14M	46.50M	66.14M	46.50M	46.63M	66.14M	0.02M	66.14M	46.54M	66.14M	46.54M		31.70M	31.70M
Goodwill & Intangibles (Quarter)	25.51M	57.56M	57.17M	57.49M	57.46M	76.81M	57.17M	76.81M	57.17M	57.30M	76.81M	10.69M	76.81M	57.21M	76.81M	57.21M	10.67M	42.37M	42.37M	10.67M
Long-Term Deferred Tax (Quarter)																0.27M				5.78M
Other Non-Current Assets (Quarter)	0.60M	0.61M	0.61M	0.63M	0.64M	0.50M	0.59M	0.63M	0.64M	0.59M	0.55M	0.58M	0.60M	0.60M	0.61M	0.61M	0.50M	0.51M	0.54M	0.56M
Non-Current Assets (Quarter)	63.31M	63.18M	62.87M	4.87M	62.65M	61.90M	62.64M	5.67M	63.55M	63.20M	62.67M	62.58M	62.77M	62.41M	62.19M	62.22M	61.77M	46.95M	47.38M	53.43M
Assets (Quarter)	127.93M	134.75M	131.21M	174.54M	144.52M	135.92M	131.15M	123.66M	113.20M	111.69M	106.15M	101.02M	108.48M	102.80M	96.59M	113.22M	111.75M	90.80M	89.64M	112.58M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	5.73M	2.72M	3.46M	27.97M	2.96M	8.68M	2.87M	2.39M	3.00M	2.19M	2.43M	2.05M	5.68M	2.39M	4.48M	1.17M	2.00M	4.45M	1.52M	7.18M
Notes Payables (Quarter)
Payables (Quarter)	5.73M	2.72M	3.46M	27.97M	2.96M	8.68M	2.87M	2.39M	3.00M	2.19M	2.43M	2.05M	5.68M	2.39M	4.48M	1.17M	2.00M	4.45M	1.52M	7.18M
Accumulated Expenses (Quarter)	0.99M	1.33M	1.54M	2.16M	4.34M	21.00M	5.00M	3.83M	0.40M	0.58M	0.35M	3.12M	0.99M	0.41M	0.38M	1.20M	2.08M	0.79M	0.49M	1.10M
Other Accumulated Expenses (Quarter)	0.18M	0.49M	0.07M	0.18M	0.08M	0.01M	0.03M		0.04M	0.00M
Short term Debt (Quarter)	0.52M
Current Leases (Quarter)	0.79M	0.79M	0.80M	0.03M	0.72M	0.03M	0.03M	0.04M	0.05M	0.05M	0.06M	0.83M	0.05M	0.05M	1.08M	1.10M	0.06M	1.00M	0.04M	0.04M
Current Deferred Revenue (Quarter)	0.10M	0.61M	0.97M	18.12M	14.88M	15.79M	38.91M	9.42M	11.01M	32.07M	31.10M	10.81M	10.11M	9.14M	8.25M	7.39M	6.93M	5.26M	3.77M	3.33M
Total Current Liabilities (Quarter)	6.62M	6.77M	8.79M	47.12M	24.59M	25.09M	22.74M	18.98M	17.23M	16.05M	15.88M	17.96M	16.89M	15.28M	13.86M	13.98M	13.09M	10.76M	9.38M	11.37M
Non-Current Liabilities
Capital Leases (Quarter)	0.03M	0.02M	0.01M	0.03M	0.03M	0.02M	0.02M	0.08M	0.13M	0.11M	0.10M	0.09M	0.08M	0.07M	0.08M	0.07M	0.05M	0.05M	0.04M	0.03M
Non-Current Debt (Quarter)
Convertible Debt (Quarter)
Non-Current Deffered Revenue (Quarter)				32.45M	30.82M	25.77M	26.54M	27.73M	24.02M	21.69M	21.20M	18.69M	18.18M	18.54M	16.05M	14.43M	13.61M	12.75M	12.46M	12.38M
Minority Interest (Quarter)	-1.10M	-1.11M	-1.12M	-1.32M	-1.33M	-1.35M	-1.40M	-1.40M	-1.44M	-1.41M	-1.46M	-1.40M	-1.41M	-1.43M	-1.39M	-1.37M	-1.37M	-1.27M	-1.24M	-1.20M
Non-Current Deferred Tax Liability (Quarter)	2.08M	1.91M	0.89M	2.08M	2.08M	2.08M	2.08M	2.08M	0.27M	0.27M	0.27M	0.27M	0.27M	0.27M	0.27M	0.27M	0.27M	0.27M	0.27M	0.02M
Operating Leases (Quarter)	2.22M	2.08M	1.89M	1.94M	1.78M	1.46M	2.22M	2.86M	2.54M	2.30M	2.05M	1.98M	2.07M	1.77M	1.53M	1.29M	1.01M	1.06M	1.51M	1.53M
Other Non-Current Liabilities (Quarter)	0.42M		0.04M	0.03M	0.01M	0.00M	0.00M	0.00M	0.00M	0.00M						6.16M	6.06M	18.80M	45.17M	43.91M
Total Non-Current Liabilities (Quarter)	10.94M		11.58M	83.62M	59.30M	54.42M	53.59M	51.73M	44.19M	40.43M		39.00M				30.05M	28.04M	24.89M	23.67M	25.33M
Total Liabilities (Quarter)	11.36M	11.15M	11.62M	83.65M	59.30M	54.42M	53.59M	51.73M	44.19M	40.43M	39.49M	39.00M	37.49M	35.93M	31.80M	36.21M	34.10M	43.69M	68.84M	69.24M
Shareholder's Equity
Total Debt (Quarter)	0.52M
Common Equity (Quarter)	116.57M	123.60M	119.59M	90.90M	85.22M	81.50M	77.55M	71.94M	69.02M	71.26M	66.66M	62.02M	70.99M	66.88M	64.79M	78.38M	77.66M	47.11M	20.80M	44.55M
Shareholder's Equity (Quarter)	116.57M	123.60M	119.59M	90.90M	85.22M	81.50M	77.55M	71.94M	69.02M	71.26M	66.66M	62.02M	70.99M	66.88M	64.79M	77.01M	77.66M	47.11M	20.80M	43.35M
Liabilities and Shareholders Equity (Quarter)	127.93M	134.75M	131.21M	174.54M	144.52M	135.92M	131.15M	123.66M	113.20M	111.69M	106.15M	101.02M	108.48M	102.80M	96.59M	113.22M	111.75M	90.80M	89.64M	112.58M
Treasury Shares (Quarter)								0.94M			0.76M	0.67M	0.50M	0.50M	0.50M	0.50M	0.33M	0.33M	0.33M	0.32M
Retained Earnings (Quarter)	-2.09M	-300.28M	-3.43M	-337.10M	-344.18M	-3.36M	-3.18M	-363.37M	-367.74M	-372.97M	-380.08M	-3.07M	-391.40M	-2.47M	-400.19M	-2.88M	-407.60M	-438.07M	-4.29M	-3.92M
Preferred Shares (Quarter)

Research Tools

Lineage Cell Therapeutics Balance Sheet (2010-2025) | LCTX

Create an account

Sign In

Reset Password